Bowen Acquisition Corp Reports Q2 2025 Financial Results with Decreased Net Income and Assets

Bowen Acquisition Corp has reported its financial results for the second quarter of 2025, revealing a net income of $750,303 for the three months ended June 30, 2025, compared to a net income of $816,754 for the same period in 2024. The company’s revenue primarily stems from interest income on investments held in a trust account, which amounted to $88,405 for the quarter, a significant decrease from $941,850 in the prior year. For the six months ending June 30, 2025, Bowen reported a net loss of $1,289,691, contrasting with a net income of $1,603,116 for the same period in 2024. The decline in profitability is attributed to increased operating costs and a loss on the issuance of a forward purchase agreement (FPA) liability.

The company’s total assets have decreased sharply from $76.0 million at the end of 2024 to $8.5 million as of June 30, 2025. This decline is primarily due to a significant reduction in the investment held in the trust account, which fell from $75.8 million to $8.3 million during the same period. Current liabilities also increased to $2.1 million from $1.1 million, driven by accrued expenses and a promissory note related to the business combination efforts. The shareholders’ deficit widened to $1.9 million, up from $799,056 at the end of 2024, reflecting the company's ongoing financial challenges.

In terms of strategic developments, Bowen Acquisition Corp is actively pursuing a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd. The company has entered into a forward purchase agreement to facilitate this merger, which is still pending regulatory approvals. As of June 30, 2025, Bowen had 744,473 shares subject to possible redemption, down from 6.9 million shares at the end of 2024, indicating a significant reduction in shareholder interest. The company has also engaged EBC as an advisor for the business combination, which will incur additional costs upon completion.

Operationally, Bowen has not yet commenced any revenue-generating activities, as it remains focused on identifying and executing its initial business combination. The company reported a working capital deficit of $1.9 million as of June 30, 2025, raising concerns about its ability to continue as a going concern. Management has indicated that it may seek additional funding from related parties to support its operations and complete the business combination. The company has until December 14, 2025, to finalize this merger, or it may face liquidation.

Looking ahead, Bowen Acquisition Corp's management has expressed uncertainty regarding its ability to complete a business combination within the required timeframe. The company is actively working to address its financial challenges and is exploring options to secure additional funding. The ongoing developments in its merger with Shenzhen Qianzhi will be critical in determining the company's future financial stability and operational viability.